Abstract
Get full access to this article
View all access options for this article.
References
1.JBS-2: Joint British Societies’ guidelines on prevention of cardiovascular disease in clinical practice. (2005). Heart, 91 (Suppl.5), v1–v52 .
2.National Institute for Health and Care Excellence guideline CG181. (2014). Cardiovascular disease: Risk assessment and reduction, including lipid modification. Retrieved from www.nice.org.uk/guidance/CG181 .
3.National Institute for Health and Care Excellence. (2014). Clinical Knowledge Summary. CVD risk assessment and management. Retrieved from https://cks.nice.org.uk/cvd-risk-assessment-and-management .
4.Scottish Intercollegiate Network clinical guideline 97. (2007). Risk estimation and the prevention of cardiovascular disease. Retrieved from www.sign.ac.uk/guidelines/fulltext/97/contents.html .